Pune, India -- (SBWIRE) -- 02/07/2018 -- The Clinical Chemistry Analyzer Market accounted to USD 9.2 billion in 2016 growing at a CAGR of 6.0% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Market Definition: Global Clinical Chemistry Analyzer Market

Clinical chemistry analyzer are the devices used to calculate the concentration of certain metabolites, electrolytes, proteins, and/or drugs in samples of serum, plasma, urine, cerebrospinal fluid, or other body fluids. These devices are used in hospitals, clinics, research laboratories. The increasing prevalence of chronic diseases, such as diabetes drives the market.

Get PDF Brochure @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-clinical-chemistry-analyzer-market          

Major market drivers and restraints: Global Clinical Chemistry Analyzer Market



- Rapidly aging population

- Increasing healthcare expenditure

- Increasing prevalence of lifestyle diseases

- Increasing use of point of care testing devices

- Increase in laboratory automation

- Stringent regulatory policies for medical devices


Market Segmentation: Global Clinical Chemistry Analyzer Market



- The clinical chemistry analyzer market is segmented by product type into analyzers and reagents. Analyzers are further sub segmented into small, medium, large and very large. The reagents are further sub segmented into calibrators, controls, standards and others reagents.

- By type of test the market is segmented into liver panels, electrolyte panels, thyroid function panels, lipid profiles, basic metabolic panels and renal profiles.

- By end-user the global clinical chemistry analyzer market is segmented into hospitals, diagnostic centers, research institutions, and pharmaceutical & biotechnology companies.

- On the basis of geography, clinical chemistry analyzer market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.


Have Any Query? Ask Ours Expert @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-clinical-chemistry-analyzer-market          

Competitive Analysis: Global Clinical Chemistry Analyzer Market

The clinical chemistry analyzer market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of clinical chemistry analyzer market for global, Europe, North America, Asia Pacific and South America.

Major Market Competitors: Global Clinical Chemistry Analyzer Market

Some of the major players operating in clinical chemistry analyzer market are

Abbott, Danaher, ThermoFisher Scientific Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Siemens AG, ELITechGroup, HORIBA, Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Randox Laboratories Ltd., Ortho Clinical Diagnostics, Nova Biomedical, Sysmex Corporation, BioSystems Diagnostics Pvt. Ltd., DiaSys Diagnostic Systems GmbH, Endress+Hauser Management AG, Diatron, SFRI, EKF and Medica Corporation among others.

Know More About our Knowledge Store @ http://databridgemarketresearch.com/reports/global-clinical-chemistry-analyzer-market/